NEW
Font size
WorksheetsContents and Generic Drug Approval Characteristics
Total questions: 75
Worksheet time: 38mins
Which characteristic is required for a generic drug to receive FDA approval?
Different active ingredients than the reference drug
The same active ingredients as the pioneer drug
Unique clinical indications not on the label
A novel mechanism distinct from the brand drug
Which set must be identical between a generic and its reference product?
Packaging color and design elements
Manufacturing company ownership details
Strength, dosage form, and route of administration
Distribution channels and pharmacy networks
What does bioequivalence ensure for a generic product?
Same safety warnings and labeling text
Similar rate and extent of absorption
Equivalent market price to the brand
Identical manufacturing equipment models
Which regulatory framework governs manufacturing standards for generics?
HIPAA privacy requirements
DEA controlled substance rules
FTC advertising guidelines
cGMP regulations by the FDA
A student compares two tablets with identical strength and route but different inactive fillers. Which conclusion is most accurate?
They cannot be FDA approved together
They may differ in active ingredients
They can be generic if bioequivalent
They violate labeling indication rules
Which drug substance property most directly increases dissolution rate by expanding surface area?
Smaller particle size increases exposed area
Higher lipid solubility lowers exposed area
Larger particle size reduces exposed area
Crystalline form lowers exposed area
A compound shows faster oral absorption when converted from crystalline to amorphous. What mechanism best explains this change?
Crystalline form has higher vapor pressure
Crystalline form has higher surface tension
Amorphous form has lower lattice energy
Amorphous form has stronger ionic bonds
Selecting a salt form for a weak base mainly aims to modify which parameter to enhance bioavailability?
Intrinsic membrane permeability
Hepatic metabolism pathway
Aqueous solubility and dissolution rate
Gastric emptying time
For a weakly acidic drug, which pH condition maximizes its ionization and aqueous solubility?
pH much lower than pKa value
pH approximately equal to pKa value
pH equal to 7 regardless of pKa
pH much higher than pKa value
Which statement best links lipid solubility to oral bioavailability?
Higher lipid solubility impairs membrane diffusion
Higher lipid solubility often aids membrane permeation
Lower lipid solubility increases first-pass effect
Lower lipid solubility guarantees faster dissolution
Which excipient primarily adds bulk to tablets without pharmacological activity?
Fillers increase dosage unit mass
Binders improve particle adhesion
Lubricants reduce die wall friction
Coatings modify release profiles
A tablet disintegrates slowly despite fast dissolution of fragments. Which excipient should be adjusted first?
Increase disintegrating agents quantity
Switch to stronger preservatives
Reduce coloring agents intensity
Add more flavoring agents
Which pair of excipients most directly improves flow and reduces tooling friction during compression?
Lubricants and glidants
Binders and coatings
Suspending and flavoring agents
Preservatives and stabilizers
To sustain drug suspension uniformity in a liquid preparation, which excipient is most essential?
Coloring agents for visibility
Suspending agents for dispersion
Surface active agents for taste
Stabilizing agents for sterility
An enteric-coated tablet is designed primarily to achieve which outcome?
Increase tablet color intensity
Protect drug from gastric acidity
Enhance tablet mechanical strength
Disintegrate rapidly in the stomach
Which dosage form property most directly affects how quickly a tablet breaks into granules after ingestion?
Disintegration time of the tablet matrix
Dissolution time in intestinal fluid
Gastric emptying time after a meal
Product age under proper refrigeration
Which change is most likely to slow the rate at which drug goes into solution from a solid oral dosage?
Shorter disintegration time of the tablet
Higher dissolution time of the drug particles
Younger product age with fresh excipients
Faster gastric emptying into the duodenum
A capsule stored for years in high humidity shows reduced bioavailability. Which factor most plausibly explains this outcome?
Gastric contents at administration
Intestinal transit time changes
Product age and storage conditions
Fluids taken with the dose
Which physiologic factor primarily determines how long a drug remains in the stomach before reaching the small intestine?
Gastrointestinal pH in the lumen
Intestinal transit time through colon
Drug metabolism during first pass
Gastric emptying time of the stomach
Which scenario would most likely decrease oral bioavailability by reducing absorption window in the small intestine?
Prolonged intestinal transit time with ileus
Shortened intestinal transit time with diarrhea
Neutral gastrointestinal pH after antacids
Concomitant fluids increasing dissolution
For a weakly basic drug, which change could reduce its solubility and delay absorption in the stomach?
Faster gastric emptying after exercise
Higher gastrointestinal pH after antacid
Longer product age in dry storage
Lower gastrointestinal pH from fasting
Which interaction is most consistent with reduced bioavailability through metabolism before systemic circulation?
Prolonged gastric emptying after a fatty meal
Enhanced first-pass metabolism in the liver
Increased dissolution time in the gut lumen
Shortened intestinal transit due to laxatives
A patient takes a tablet with a high-fat meal and experiences delayed onset. Which paired factors most likely contributed?
Other drugs and first-pass metabolism
Fluids and dissolution time
Product age and intestinal transit
Food and gastric emptying time
Which statement best explains why two therapeutically equivalent drugs may not be interchangeable for a specific patient?
Active ingredients produce opposite clinical effects
Therapeutic equivalence requires identical packaging
Different inert excipients can trigger hypersensitivity
Bioequivalence guarantees identical patient experiences
A patient develops a rash after switching from a brand to a generic with the same active ingredient. Which factor most likely caused the reaction?
Change in inert excipient causing hypersensitivity
Loss of therapeutic equivalence of the generic
Placebo effect from new tablet appearance
Incorrect dose due to stronger active ingredient
A long-term patient becomes distressed when dispensed a product that differs in color, flavor, shape, or packaging. What is the most appropriate initial action?
Reduce dose to minimize perceived differences
Report an adverse drug reaction to regulators
Advise continuing without addressing concerns
Discuss preferences and consider an alternative product
Which term refers to placing a drug under the tongue for absorption?
Intranasal within nasal cavity
Per-oral via gastrointestinal tract
Oral administration in the mouth
Sublingual under the tongue
Per-oral administration primarily delivers the drug to which site?
Joint fluid space
Beneath the skin layer
Vein in systemic circulation
Gastrointestinal tract via mouth
Which route is correctly matched with the site 'mouth'?
Intranasal spray
Per-oral ingestion
Oral administration
Sublingual placement
Which parenteral route targets a vein directly?
Subcutaneous delivery
Intravenous administration
Intradermal injection
Intramuscular injection
Which term denotes drug delivery into an artery?
Intraarterial route
Intravenous route
Intraosseous route
Intracardiac route
Administration 'intracardiac' indicates delivery into which site?
Spine within the canal
Heart chamber or muscle
Joint synovial space
Bone marrow cavity
Intraspinal (intrathecal) administration delivers medication to which area?
Within the spine space
Under the skin tissue
Into an arterial lumen
Inside a joint capsule
Which route places the drug within bone tissue?
Subcutaneous route
Intradermal route
Intramuscular route
Intraosseous route
Which route is intended for a joint cavity?
Intraarterial pathway
Intracardiac pathway
Intranasal pathway
Intraarticular pathway
The term 'intrasynovial' best describes administration to which site?
Joint fluid area
Subcutaneous fat layer
Spinal canal space
Arterial blood flow
Intradermal administration targets which anatomical layer?
Muscle fibers
Skin dermal layer
Nasal mucosa
Vein lumen
Which route describes injection beneath the skin?
Subcutaneous route
Intramuscular route
Intravenous route
Intradermal route
Which term indicates delivery directly into muscle tissue?
Intravenous administration
Intraosseous administration
Intramuscular administration
Intraarticular administration
Which non-parenteral route is most appropriate for tablets swallowed with water?
Rectal route
Oral route
Sublingual route
Intranasal route
A nitroglycerin tablet placed for rapid absorption under the tongue uses which route?
Per-oral ingestion
Sublingual placement
Intramuscular injection
Transdermal delivery
Which route is categorized under parenteral administration?
Sublingual placement
Intravenous injection
Intranasal spray
Oral ingestion
Transdermal delivery primarily relies on absorption through which site?
Within the gastrointestinal tract
Into the nasal passages
Across the skin surface
Directly into a vein
Which route uses the nasal mucosa for systemic or local effects?
Intraspinal route
Rectal route
Intraosseous route
Intranasal route
Suppositories are most consistent with which administration route?
Oral route
Rectal route
Intravenous route
Intramuscular route
A patient needing rapid vascular access when veins are inaccessible may receive drugs via which route?
Intradermal injection
Transdermal patch
Intraosseous infusion
Sublingual tablet
Which administration route delivers medication specifically to the conjunctiva?
Aural route to external ear
Conjunctival route to conjunctiva
Intranasal route to nasal cavity
Transdermal route to skin surface
A drug labeled intraocular is intended to be placed where?
Into the nasal passages
On the skin surface
Inside the eye structures
Within the external ear canal
Which route targets the ear for local therapy?
Vaginal administration to vagina
Rectal administration to rectum
Intrarespiratory administration to lungs
Aural administration to ear
A nebulized bronchodilator for asthma is best categorized under which route?
Intrarespiratory delivery to lungs
Rectal delivery to rectum
Transdermal delivery to skin
Intranasal delivery to nose
Select the route that corresponds to placement in the vagina.
Vaginal route to vagina
Aural route to ear
Intraocular route to eye
Conjunctival route to conjunctiva
Which statement best defines the first-pass effect?
Pulmonary distribution bypassing the systemic circulation
Pre-systemic hepatic metabolism reducing active drug
Enhanced renal excretion increasing drug half-life
Gastrointestinal absorption increasing peak plasma level
Which routes most strongly influence differences in drug absorption among dosage forms?
Brand name and tablet color
Patient age and body mass index
Packaging and storage temperature
Formulation and route of administration
During oral administration, what vascular pathway carries absorbed drug toward the liver?
Portal vein from the gastrointestinal tract
Pulmonary vein from the alveolar sacs
Renal artery from the glomerular capillaries
Coronary vein from myocardial tissue
What is the immediate consequence when a drug undergoes extensive first-pass metabolism?
Decreased systemic bioavailability of the parent drug
Increased time to reach therapeutic window
Reduced drug distribution to the gastrointestinal tract
Enhanced protein binding within plasma albumin
Which factor determines the bioavailable fraction of an orally administered drug?
Fraction dissolved and fraction binding to packaging
Fraction filtered and fraction secreted by kidneys
Fraction absorbed and fraction escaping hepatic metabolism
Fraction inhaled and fraction exhaled unmetabolized
Which pair correctly matches metabolite activity states generated by first-pass metabolism?
Active metabolites can exert pharmacologic effects
Inactive metabolites enhance therapeutic potency
Active metabolites always have longer half-lives
Inactive metabolites always reverse toxicity
A drug with low oral bioavailability is reformulated. Which change most plausibly improves systemic exposure without increasing dose?
Use a non-oral route that bypasses hepatic first-pass
Add dye to enhance mucosal visualization in transit
Increase tablet size to delay gastric emptying time
Package the drug in light-resistant blister foil
Two oral formulations of the same drug yield different plasma levels. What primary explanation fits the material?
Differences in brand reputation and marketing claims
Differences in price and distribution channels
Differences in formulation and administration route
Differences in patient preference and pill color
Which scenario most likely reduces the need for a higher oral dose?
Reduced first-pass metabolism increases bioavailability
Stronger hepatic metabolism lowers toxicity risk
Greater gastric acid secretion accelerates absorption
Faster intestinal transit decreases dissolution time
A prodrug depends on hepatic activation. What impact can first-pass metabolism have?
Increase active metabolite formation and effect
Decrease renal clearance of the parent prodrug
Eliminate the need for any absorption process
Prevent distribution to tissues with high perfusion
Which statement accurately describes bioavailability in the context of oral dosing?
Proportion of absorbed dose reaching systemic circulation
Proportion of dose dissolving within gastric contents
Proportion of dose stored in adipose tissue
Proportion of dose binding plasma proteins tightly
A clinician observes subtherapeutic levels after oral dosing. Which reasoning step is most appropriate first?
Assume poor adherence and stop the regimen
Add a second drug with overlapping targets
Switch immediately to highest available dose
Evaluate first-pass metabolism and absorption fraction
Which expression defines the bioavailable fraction of an orally administered drug?
Dose administered minus amount metabolized presystemically
Fraction absorbed divided by hepatic extraction ratio
Fraction absorbed times fraction escaping first-pass
Fraction secreted plus fraction excreted renally
For drugs with extensive first-pass metabolism, bioavailability is typically
Equal across all administration routes
Unaffected by hepatic enzyme activity
Highest due to rapid intestinal absorption
Lowest compared to routes avoiding first-pass
Which route avoids first-pass metabolism and can be used to compensate for it?
Sublingual administration of certain drugs
Rectal suppositories with variable absorption
Transdermal patches for local dermal action
Oral tablets swallowed with water
When changing from oral to intravenous dosing for a drug with strong first-pass effect, the dose should be
Kept identical to maintain steady plasma levels
Reduced to account for higher systemic availability
Increased to overcome hepatic extraction
Adjusted only for patient body weight
Why might propranolol require a larger oral dose than parenteral dose?
Poor dissolution in gastric fluid only
Inactive metabolites after first-pass metabolism
Extensive renal reabsorption in kidneys
Enzyme induction by intestinal flora
Which statement best describes sublingual nitroglycerin absorption?
Slow gastric absorption with extensive metabolism
Rapid uptake into systemic circulation bypassing liver
Local oral mucosa action without systemic effects
Primary small intestine absorption with bile facilitation
Where is most drug absorption after oral administration typically occurring?
Small intestine due to large surface area
Stomach because of acidic environment
Esophagus through mucosal diffusion
Colon owing to prolonged transit time
A manufacturer chooses intramuscular route for a drug with high first-pass extraction. The primary rationale is
Minimize distribution volume and tissue binding
Exploit depot effect for immediate local action
Avoid presystemic metabolism and increase bioavailability
Enhance gastric emptying and dissolution rate
Switching from oral to sublingual dosing generally requires dosage
Reduction only when metabolites are active
No change because bioavailability is constant
Increase to compensate for slower absorption
Adjustment to reflect bypass of first-pass
Which scenario most likely yields local rather than systemic effects?
Topical oral mouthwash for gingivitis
Sublingual tablet of nitroglycerin
Intravenous bolus of propranolol
Oral capsule absorbed in jejunum
A drug has f = 0.25 for oral dosing. Which change most plausibly raises f?
Use a route that bypasses hepatic first-pass
Increase tablet hardness to slow disintegration
Co-administer food to delay gastric emptying
Raise dose to saturate renal excretion
A patient on a drug with inactive metabolites experiences subtherapeutic effect with standard oral dose. The most appropriate plan is
Increase oral dose or select a non-first-pass route
Reduce dose to minimize presystemic metabolism
Switch to extended-release formulation without dose change
Add a prodrug to activate intestinal enzymes
